Initiation of glucose-lowering drugs reduces the anticoagulant effect of warfarin – but not through altered drug metabolism in patients with type 2 diabetes
Ann-Cathrine Dalgård Dunvald, Flemming Nielsen, Dorte Aalund Olsen, Martin Thomsen Ernst, Louise Donnelly, Enrique Soto-Pedre, Maja Refshauge Kristiansen, Jens Steen Nielsen, Frederik Persson, Kurt Højlund, Jonna Skov Madsen, Jens Søndergaard, Ewan Pearson, Anton Pottegård, Tore Bjerregaard Stage
medRxiv 2022.10.07.22280782; doi: https://doi.org/10.1101/2022.10.07.22280782
